Noss Ilka, Ozment Tammy R, Graves Bridget M, Kruppa Michael D, Rice Peter J, Williams David L
Department of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
Department of Surgery, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA Center for Inflammation, Infectious Disease and Immunity, East Tennessee State University, Johnson City, TN, USA.
Innate Immun. 2015 Oct;21(7):759-69. doi: 10.1177/1753425915595874. Epub 2015 Jul 23.
Over the last 40 yr, the majority of research on glucans has focused on β-(1→3)-glucans. Recent studies indicate that β-(1→6)-glucans may be even more potent immune modulators than β-(1→3)-glucans. Mechanisms by which β-(1→6)-glucans are recognized and modulate immunity are unknown. In this study, we examined the interaction of purified water-soluble β-(1→6)-glucans with macrophage cell lines and primary peritoneal macrophages and the cellular and molecular consequences of this interaction. Our results indicate the existence of a specific β-(1→6)-glucan receptor that internalizes the glucan ligand via a clathrin-dependent mechanism. We show that the known β-(1→3)-glucans receptors are not responsible for β-(1→6)-glucan recognition and interaction. The receptor-ligand uptake/interaction has an apparent dissociation constant (KD) of ∼ 4 µM, and was associated with phosphorylation of ERK and JNK but not IκB-α or p38. Our results indicate that macrophage interaction with β-(1→6)-glucans may lead to modulation of genes associated with anti-fungal immunity and recruitment/activation of neutrophils. In summary, we show that macrophages specifically bind and internalize β-(1→6)-glucans followed by activation of intracellular signaling and modulation of anti-fungal immune response-related gene regulation. Thus, we conclude that the interaction between innate immunity and β-(1→6)-glucans may play an important role in shaping the anti-fungal immune response.
在过去40年里,对葡聚糖的大多数研究都集中在β-(1→3)-葡聚糖上。最近的研究表明,β-(1→6)-葡聚糖可能是比β-(1→3)-葡聚糖更强效的免疫调节剂。β-(1→6)-葡聚糖被识别并调节免疫的机制尚不清楚。在本研究中,我们检测了纯化的水溶性β-(1→6)-葡聚糖与巨噬细胞系及原代腹膜巨噬细胞的相互作用,以及这种相互作用的细胞和分子后果。我们的结果表明存在一种特异性的β-(1→6)-葡聚糖受体,它通过网格蛋白依赖机制内化葡聚糖配体。我们发现已知的β-(1→3)-葡聚糖受体并不负责β-(1→6)-葡聚糖的识别和相互作用。受体-配体摄取/相互作用的表观解离常数(KD)约为4µM,并且与ERK和JNK的磷酸化有关,但与IκB-α或p38无关。我们的结果表明巨噬细胞与β-(1→6)-葡聚糖的相互作用可能导致与抗真菌免疫相关基因的调节以及中性粒细胞的募集/激活。总之,我们表明巨噬细胞特异性结合并内化β-(1→6)-葡聚糖,随后激活细胞内信号传导并调节抗真菌免疫反应相关的基因调控。因此,我们得出结论,先天免疫与β-(1→6)-葡聚糖之间的相互作用可能在塑造抗真菌免疫反应中起重要作用。